Bicara Therapeutics Inc (BCAX) Annual Balance Sheets

Annual · GAAP · USD millions
Access BCAX quarterly Balance Sheets →
The balance sheet data below highlights changes in Bicara Therapeutics Inc's financial position over recent quarters.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024)
Assets
Cash & cash equivalent96.69
Marketable Securities, Current SH318.12
Cash & Short-term Investments414.00
Prepaid Expense And Other Assets Current7.25
Total Current Assets422.05
Equipment/Property/Plant Net0.33
Other Assets, Noncurrent8.61
Operating Lease Right Of Use Asset1.70
Total Assets430.99
Liabilities
Accounts Payable, Current AC5.52
Accrued Liabilities, Current AC18.90
Other Liabilities, Current4.54
Total Current Liabilities28.95
Total Long-term Debt0.00
Other liabilities, Noncurrent0.59
Operating Lease Liability Current1.12
Operating Lease Liability Noncurrent0.59
Total Liabilities29.54
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock760.17
Retained Earnings / Accumulated Deficit-358.97
Other Equity0.24
Common Stockholder's Equity401.45
Total Stockholder's Equity401.45
Liabilities & Stockholder's Equity430.99
4 historic quarters locked

Sign in to unlock the full Bicara Therapeutics Inc balance sheet history.

About Bicara Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-022010

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License